Silver Book Fact

According to the Pharmaceutical Research and Manufacturers of America, a radiopharmaceutical currently in development is a synthetic version of a substance derived from scorpions–chlorotoxin. This could be a powerful weapon in the fight against high-grade gliomas, a highly invasive cancer that sends cancerous cells throughout the brain and spinal cord. Chlorotoxin binds specifically to tumor cells–but not normal cells.

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • FDA approved cancer advances
     
  • Increase in 5-year survival rate for cancer
     
  • 5-Year Relative Survival Rates for Cancers in U.S.  
  • Between August 2004 and July 2014, the FDA approved: Six new anticancer therapeutics Five new uses for previously approved anticancer therapeutics Two new uses for imaging agents One new use for a screening test  
  • A 10 percent reduction in cancer-related deaths in the U.S. would be worth an estimated $4.4 trillion to current and future generations.